Sandesh Seth insider trades

Open-market stock purchases and sales by Sandesh Seth, Chief Executive Officer at Actinium Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 25, 2013.

Track record: 100% of 11 scored buys are up 5% or more since purchase, averaging +93%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ATNM Actinium Pharmaceuticals, Inc: 13 buys, last Aug 18, 2025
  • RLMD Relmada Therapeutics, Inc: 11 buys, last Dec 15, 2015

Get free alerts when Sandesh Seth files a new trade →